Zobrazeno 1 - 10
of 57
pro vyhledávání: '"Recurrent Prostate Carcinoma"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tobias Maurer, Jan C. Peeken, Markus Kroenke, Matthias Eiber, Stephanie E. Combs, Mohamed A. Shouman, Isabel Rauscher, Jürgen E. Gschwend
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging
Eur. J. Nucl. Med. Mol. Imaging 47, 2968-2977 (2020)
Eur. J. Nucl. Med. Mol. Imaging 47, 2968-2977 (2020)
Purpose In recurrent prostate carcinoma, determination of the site of recurrence is crucial to guide personalized therapy. In contrast to prostate-specific membrane antigen (PSMA)–positron emission tomography (PET) imaging, computed tomography (CT)
Publikováno v:
American Journal of Roentgenology. 214:W37-W43
OBJECTIVE. The purpose of this article is to evaluate the MR findings of prostatic remnant after prostatectomy and estimate the prevalence of prostatic remnant in patients that undergo MRI after prostatectomy. MATERIALS AND METHODS. Sixty-six patient
Autor:
Mathias Schreckenberger, Helmut J. Wieler, Ludwin Trampert, Hans-Georg Buchholz, Manuela A Hoffmann, Jonas Müller-Hübenthal, Thomas Höfner
Publikováno v:
Oncotarget
Background: The aim of the present study is to analyze the efficacy of 68Gallium (Ga)-PSMA-11 PET/CT for detecting and localizing recurrent prostate carcinoma (PC) in patients with different prostate-specific antigen (PSA), PSA velocity (PSAvel) and
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 104:801-808
Purpose The purpose of this study is to assess the utility of 68Gallium prostate-specific membrane antigen (PSMA) Division of Radiopharmaceutical Chemistry (DKFZ)-PSMA-11 positron emission tomography (PET)–computed tomography (CT), compared with st
Publikováno v:
Clin Nucl Med
PURPOSE: The aims of this study were to report on our initial experience using (18)F-fluciclovine PET/CT to detect recurrent prostate carcinoma in patients with low serum prostate-specific antigen (PSA) after definitive treatment of primary disease a
Publikováno v:
Indian Journal of Cancer.
Imaging of prostate cancer has recently had new modalities. Ga-68 Prostate Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) has gained important diagnostic role in the management of the patients with prostate
Autor:
Ismaheel O. Lawal, Thomas Ebenhan, Christophe Van de Wiele, Tebatso Boshomane, Mike Sathekge, Mariza Vorster, Jan Rijn Zeevaart, Thabo Lengana, Alex Maes, Alfred O. Ankrah, Neo P. Mokgoro
Publikováno v:
Nuclear Medicine Communications. 39:179-185
Objective To compare the diagnostic accuracy of Ga-prostate-specific membrane antigen (PSMA)-HBED-CC PET/computed tomography (CT) imaging for the detection of androgen-dependent recurrent prostate carcinoma (ADPC) in Black South Africans (BSAs) versu
Publikováno v:
Clinical nuclear medicine. 44(9)
We present a case demonstrating increased diagnostic difficulty in interpretation of F-flucyclovine PET/CT in a patient with beta-thalassemia. F-flucyclovine PET/CT demonstrated diffuse increased marrow activity. Additional findings of extramedullary
Publikováno v:
Clinical Nuclear Medicine. 45:223-224
We report the case of a 74-year-old man with suspected recurrent prostate carcinoma who underwent F-PSMA-1007 PET/CT for restaging the disease. PET/CT imaging presented an incidentaloma with intense F-PSMA-1007 uptake in the right thyroid lobe. Biops